Zobrazeno 1 - 10 of 11 pro vyhledávání: '"David G.M. Carville"'
2
Point-of-Care Monitoring for Optimal Antiplatelet Therapy in Acute Clinical Settings
Autor: David G.M. Carville, Helen Ridgway, Richard L. Rullman, Kirk E. Guyer
Publikováno v: Point of Care: The Journal of Near-Patient Testing & Technology. 6:208-212
Here we describe the utility of a point ofcare (POC) test platform (PlateletWorks®) for monitoring platelet response to ADP and arachidonic acid (AA) as the agonists Methods & Procedure: PlateletWorks (Helena Laboratories, Beaumont, TX) evaluates no
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0e8422a03652e01d491d6abe86b3500d
https://doi.org/10.1097/poc.0b013e31812e94f0
Zobrazit plný text záznamu
5
Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet Aggregation
Autor: Amy S. Hopp, Charlene J. Neer, Kevin Horowitz, Paul B. Watkins, Alan R. Tait, Wei C. Lau, Eric R. Bates, David G.M. Carville, Kirk E. Guyer, Lucy A. Waskell
Publikováno v: Circulation. 107:32-37
Background— We observed that the prodrug clopidogrel was less effective in inhibiting platelet aggregation with coadministration of atorvastatin during point-of-care platelet function testing. Because atorvastatin is metabolized by cytochrome P450
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef98324be81834d68a126e3c865b8f3f
https://doi.org/10.1161/01.cir.0000047060.60595.cc
Zobrazit plný text záznamu
6
Plateletworks: a novel point of care platelet function screen
Autor: James Campbell, David G.M. Carville, Helen Ridgway
Publikováno v: Molecular diagnosistherapy. 12(4)
Platelet function is critically important in the acute-care settings of cardiopulmonary bypass surgery and percutaneous coronary intervention, which are commonly associated with the adverse vascular events of hemorrhage and thrombosis, respectively.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::962505c0b3829eb0d8e8ab006354bd97
https://pubmed.ncbi.nlm.nih.gov/18652521
Zobrazit plný text záznamu
7
Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance
Autor: Paul B. Watkins, Kirk E. Guyer, Alan R. Tait, Eric R. Bates, Wei C. Lau, Amy S. Hopp, Paul A. Gurbel, David G.M. Carville, Charlene J. Neer
Publikováno v: Circulation. 109(2)
Background— Interindividual variability of platelet inhibition after aspirin or clopidogrel administration has been described. Additionally, aspirin resistance and clopidogrel resistance occur in some individuals. Because the prodrug clopidogrel is
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::085d8338b57706011ccff5982c646947
https://pubmed.ncbi.nlm.nih.gov/14707025
Zobrazit plný text záznamu
9
Use of ICHOR-platelet works to assess platelet function in patients treated with GP IIb/IIIa inhibitors
Autor: Kirk E. Guyer, Elson Thomas, David G.M. Carville, Mohamad Ali, Nasser Lakkis, Sima George
Publikováno v: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions. 53(3)
Platelet glycoprotein GP IIb/IIIa inhibitors have been recently approved for use in treating patients with acute coronary syndromes and those undergoing PCI. The purpose of this study was to assess the feasibility of using a new device, the ICHOR pla
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::729e2810f2fcdbf4a93a852144b2abec
https://pubmed.ncbi.nlm.nih.gov/11458412
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje